Drug-Resistant TB—Problem and Management: a Review

Authors

  • Ejaz Shaikh Associate Professor Department of Tahaffuzi-wa- Samaji Tib, ZVM Unani Medical College and Hospital, Azam Campus, Pune, Maharashtra, India
  • Umair Shaikh
  • Ansari Farha
  • Rehan Safee

Abstract

Tuberculosis (TB) is one of the oldest diseases known to affect humans. TB is a major cause of death worldwide. The bacteria Mycobacterium tuberculosis is the causative agent of TB. It usually affects the lungs and causes pulmonary TB. The intestine, meninges, bones, joints, lymph glands, skin and other tissues of the body are also affected. TB caused by drug-susceptible strains is curable in virtually all the cases after proper treatment. The untreated TB may be fatal within 5 years in 50%–65% of the cases. Drug-resistant TB is a worldwide threat. Treatment of drug-resistant TB is more complex, less effective, more toxic, and much more expensive than treatment of patients infected with drug-susceptible TB strains. Treatment of multidrug-resistant (MDR) TB can take at least two years and the results are poor. Patient with MDR-TB may need hospitalization and isolation which adds to the cost of treatment, to prevent transmission of primary resistant strains to other; careful precautions are necessary to prevent transmission.

Keywords: drug-resistant tuberculosis, management, multidrug-resistant tuberculosis (MDR-TB), Mycobacterium tuberculosis, tuberculosis (TB)

Cite this Article
Umair Shaikh, Ejaz Shaikh, Ansari Farha, Rehan Safee. Drug-Resistant TB—Problem and Management: a Review. Research & Reviews: A Journal of Unani, Siddha and Homeopathy. 2019; 6(3): 30–34p.

Downloads

Published

2019-12-26

Issue

Vol. 6 No. 3 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.